Pmda - Pharmaceuticals and Medical Devices Agency
Menu
Close

Regulatory Science/The Science Board/Standard Development

The 4th Subcommittee on Rare Cancers

Press Release

Date and Time:April 28, 2017 from 4pm to 6pm

Agenda / List of Handouts

Agenda
  1. Clinical Trials of Rare Cancers Area (Dr. Taro Shibata, a Member of the Subcommittee)
  2. Clinical Sarcoma Research, Rare Cancers Research and Development (Dr. Seiichi Matsumoto, a Member of the Subcommittee)
  3. Experience in Childhood Cancers Research Group, Rare Cancers Research and Development (Dr. Shuki Mizutani, a Member of the Subcommittee)
  4. Reviewing Rare Cancers (Office of New Drug V, PMDA)
  5. Points to Consider and Future Plan
List of Handouts
  • Document 1 The 3rd Subcommittee Minutes Summary
  • Document 2 The 1st-3rd Subcommittee Discussion Summary
  • Document 3 Lecture Materials (Dr. Taro Shibata, a Member)
  • Document 4 Lecture Materials (Dr. Seiichi Matsumoto, a Member)
  • Document 5 Lecture Materials (Dr. Shuki Mizutani, a Member)
  • Document 6 Lecture Materials (Office of New Drug V, PMDA)